Cargando…

Topical Treatment With Oxaliplatin for the Prevention of Port-Site Metastases in Laparoscopic Surgery for Colorectal Cancer

BACKGROUND: The development of port-site metastases following laparoscopic resection of various malignancies continues to be a disturbing issue for laparoscopic surgeons. Previous studies revealed promising results with oxaliplatin, a third-generation platinum compound, as a first-line treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tai, Yun-Sheng, Cuenca Abente, Federico, Assalia, Ahmad, Ueda, Kazuki, Gagner, Michel
Formato: Texto
Lenguaje:English
Publicado: Society of Laparoendoscopic Surgeons 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016121/
https://www.ncbi.nlm.nih.gov/pubmed/16882412
_version_ 1782195672528715776
author Tai, Yun-Sheng
Cuenca Abente, Federico
Assalia, Ahmad
Ueda, Kazuki
Gagner, Michel
author_facet Tai, Yun-Sheng
Cuenca Abente, Federico
Assalia, Ahmad
Ueda, Kazuki
Gagner, Michel
author_sort Tai, Yun-Sheng
collection PubMed
description BACKGROUND: The development of port-site metastases following laparoscopic resection of various malignancies continues to be a disturbing issue for laparoscopic surgeons. Previous studies revealed promising results with oxaliplatin, a third-generation platinum compound, as a first-line treatment in advanced colorectal cancer. This study evaluates the effect of topical application of oxaliplatin on the development of port-site metastases in an experimental murine model. METHODS: Nineteen female BDIX rats (immunocompe-tent, 6 weeks old) underwent a sham laparoscopic operation after 1x10(7) viable rat colon carcinoma viable cells (LMCR) had been injected into their peritoneal cavities. Three trocars (1 central camera port and 2 additional lateral ports) were introduced into the abdomen, and a pneumoperitoneum was created with carbon dioxide. Ten minutes after LMCR, cells were injected into the peritoneal cavity, the 2 lateral trocars were removed and carbon dioxide insufflation was maintained for an additional 5 minutes to allow for tumor cell seeding. Oxaliplatin (0.198 mg/kg) was then topically applied to 1 trocar site intramuscularly, while the other site was left untreated. One week later, the animals were euthanized, and the port sites were histologically examined for evidence of metastases. RESULTS: The rate of tumor implantation at the muscle layer in control sites was 68% (13/19) compared with 37% (7/19) at oxaliplatin-treated sites (P=0.1). Also, no significant differences were detected in port-site metastasis rates in other untreated layers of the abdominal wall. CONCLUSION: Intramuscular topical application of oxaliplatin may not decrease the incidence of port-site metastasis in a syngeneic animal model of colon cancer. Nevertheless, we can see the tendency of declination. Further studies are needed to better determine its possible therapeutic role in high-risk humans undergoing laparoscopic resection of colorectal malignancies.
format Text
id pubmed-3016121
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Society of Laparoendoscopic Surgeons
record_format MEDLINE/PubMed
spelling pubmed-30161212011-02-17 Topical Treatment With Oxaliplatin for the Prevention of Port-Site Metastases in Laparoscopic Surgery for Colorectal Cancer Tai, Yun-Sheng Cuenca Abente, Federico Assalia, Ahmad Ueda, Kazuki Gagner, Michel JSLS Scientific Papers BACKGROUND: The development of port-site metastases following laparoscopic resection of various malignancies continues to be a disturbing issue for laparoscopic surgeons. Previous studies revealed promising results with oxaliplatin, a third-generation platinum compound, as a first-line treatment in advanced colorectal cancer. This study evaluates the effect of topical application of oxaliplatin on the development of port-site metastases in an experimental murine model. METHODS: Nineteen female BDIX rats (immunocompe-tent, 6 weeks old) underwent a sham laparoscopic operation after 1x10(7) viable rat colon carcinoma viable cells (LMCR) had been injected into their peritoneal cavities. Three trocars (1 central camera port and 2 additional lateral ports) were introduced into the abdomen, and a pneumoperitoneum was created with carbon dioxide. Ten minutes after LMCR, cells were injected into the peritoneal cavity, the 2 lateral trocars were removed and carbon dioxide insufflation was maintained for an additional 5 minutes to allow for tumor cell seeding. Oxaliplatin (0.198 mg/kg) was then topically applied to 1 trocar site intramuscularly, while the other site was left untreated. One week later, the animals were euthanized, and the port sites were histologically examined for evidence of metastases. RESULTS: The rate of tumor implantation at the muscle layer in control sites was 68% (13/19) compared with 37% (7/19) at oxaliplatin-treated sites (P=0.1). Also, no significant differences were detected in port-site metastasis rates in other untreated layers of the abdominal wall. CONCLUSION: Intramuscular topical application of oxaliplatin may not decrease the incidence of port-site metastasis in a syngeneic animal model of colon cancer. Nevertheless, we can see the tendency of declination. Further studies are needed to better determine its possible therapeutic role in high-risk humans undergoing laparoscopic resection of colorectal malignancies. Society of Laparoendoscopic Surgeons 2006 /pmc/articles/PMC3016121/ /pubmed/16882412 Text en © 2006 by JSLS, Journal of the Society of Laparoendoscopic Surgeons. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits for noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited and is not altered in any way.
spellingShingle Scientific Papers
Tai, Yun-Sheng
Cuenca Abente, Federico
Assalia, Ahmad
Ueda, Kazuki
Gagner, Michel
Topical Treatment With Oxaliplatin for the Prevention of Port-Site Metastases in Laparoscopic Surgery for Colorectal Cancer
title Topical Treatment With Oxaliplatin for the Prevention of Port-Site Metastases in Laparoscopic Surgery for Colorectal Cancer
title_full Topical Treatment With Oxaliplatin for the Prevention of Port-Site Metastases in Laparoscopic Surgery for Colorectal Cancer
title_fullStr Topical Treatment With Oxaliplatin for the Prevention of Port-Site Metastases in Laparoscopic Surgery for Colorectal Cancer
title_full_unstemmed Topical Treatment With Oxaliplatin for the Prevention of Port-Site Metastases in Laparoscopic Surgery for Colorectal Cancer
title_short Topical Treatment With Oxaliplatin for the Prevention of Port-Site Metastases in Laparoscopic Surgery for Colorectal Cancer
title_sort topical treatment with oxaliplatin for the prevention of port-site metastases in laparoscopic surgery for colorectal cancer
topic Scientific Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016121/
https://www.ncbi.nlm.nih.gov/pubmed/16882412
work_keys_str_mv AT taiyunsheng topicaltreatmentwithoxaliplatinforthepreventionofportsitemetastasesinlaparoscopicsurgeryforcolorectalcancer
AT cuencaabentefederico topicaltreatmentwithoxaliplatinforthepreventionofportsitemetastasesinlaparoscopicsurgeryforcolorectalcancer
AT assaliaahmad topicaltreatmentwithoxaliplatinforthepreventionofportsitemetastasesinlaparoscopicsurgeryforcolorectalcancer
AT uedakazuki topicaltreatmentwithoxaliplatinforthepreventionofportsitemetastasesinlaparoscopicsurgeryforcolorectalcancer
AT gagnermichel topicaltreatmentwithoxaliplatinforthepreventionofportsitemetastasesinlaparoscopicsurgeryforcolorectalcancer